These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 23760185)

  • 21. Haiti 2007-2008 national measles-rubella vaccination campaign: implications for rubella elimination.
    Rainey JJ; Danovaro-Holliday MC; Magloire R; Kananda G; Lee CE; Chamouillet H; Lacapere F; Mung K; Luman ET
    J Infect Dis; 2011 Sep; 204 Suppl 2():S616-21. PubMed ID: 21954256
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Congenital rubella syndrome (CRS) in Vietnam 2011-2012--CRS epidemic after rubella epidemic in 2010-2011.
    Toda K; Reef S; Tsuruoka M; Iijima M; Dang TH; Duong TH; Nguyen VC; Nguyen TH
    Vaccine; 2015 Jul; 33(31):3673-7. PubMed ID: 26087296
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epidemiology of rubella and congenital rubella syndrome in Japan before 1989.
    Ueda K
    Vaccine; 2016 Apr; 34(16):1971-4. PubMed ID: 26469722
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Progress toward elimination of rubella and congenital rubella syndrome--the Americas, 2003-2008.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2008 Oct; 57(43):1176-9. PubMed ID: 18971920
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The use of rapid coverage monitoring in the national rubella vaccination campaign, Haiti 2007-2008.
    Lacapère F; Magloire R; Danovaro-Holliday MC; Flannery B; Chamoulliet H; Celestin EP
    J Infect Dis; 2011 Sep; 204 Suppl 2():S698-705. PubMed ID: 21954269
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of rubella vaccination strategy on the occurrence of congenital rubella syndrome.
    Lanzieri TM; Pinto D; Prevots DR
    J Pediatr (Rio J); 2007; 83(5):415-21. PubMed ID: 17853958
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The opportunity and obligation to eliminate rubella from the United States.
    Orenstein WA; Bart KJ; Hinman AR; Preblud SR; Greaves WL; Doster SW; Stetler HC; Sirotkin B
    JAMA; 1984 Apr; 251(15):1988-94. PubMed ID: 6700103
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An epidemiological assessment towards elimination of rubella and congenital rubella syndrome in Singapore.
    Chua YX; Ang LW; Low C; James L; Cutter JL; Goh KT
    Vaccine; 2015 Jun; 33(27):3150-7. PubMed ID: 25887085
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rubella control in Italy.
    Ciofi degli Atti M; Filia A; Revello MG; Buffolano W; Salmaso S
    Euro Surveill; 2004 Apr; 9(4):19-21. PubMed ID: 15192262
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Congenital rubella still a public health problem in Italy: analysis of national surveillance data from 2005 to 2013.
    Giambi C; Filia A; Rota MC; Del Manso M; Declich S; Nacca G; Rizzuto E; Bella A;
    Euro Surveill; 2015 Apr; 20(16):. PubMed ID: 25953272
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The epidemiology of rubella and congenital rubella in Australia, 1992 to 1997.
    Sullivan EM; Burgess MA; Forrest JM
    Commun Dis Intell; 1999 Aug; 23(8):209-14. PubMed ID: 10497832
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The epidemiology of rubella, 2007-18: an ecological analysis of surveillance data.
    Patel MK; Antoni S; Danovaro-Holliday MC; Desai S; Gacic-Dobo M; Nedelec Y; Kretsinger K
    Lancet Glob Health; 2020 Nov; 8(11):e1399-e1407. PubMed ID: 33069300
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Accelerated rubella control and congenital rubella syndrome prevention strengthen measles eradication: the Costa Rican experience.
    Morice A; Carvajal X; León M; Machado V; Badilla X; Reef S; Lievano F; Depetris A; Castillo-Solórzano C
    J Infect Dis; 2003 May; 187 Suppl 1():S158-63. PubMed ID: 12721908
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ongoing rubella epidemic in Osaka, Japan, in 2018-2019.
    Kanbayashi D; Kurata T; Kubo H; Kaida A; Yamamoto SP; Egawa K; Hirai Y; Okada K; Ikemori R; Yumisashi T; Yamamoto A; Yoshida H; Hirayama T; Ikuta K; Motomura K
    Western Pac Surveill Response J; 2020; 11(2):48-50. PubMed ID: 33537164
    [No Abstract]   [Full Text] [Related]  

  • 35. Progress toward measles and rubella elimination in Egypt.
    El Sayed N; Kandeel N; Barakat I; Moussa I; Alexander JP; Naouri B; Reef SE
    J Infect Dis; 2011 Jul; 204 Suppl 1():S318-24. PubMed ID: 21666180
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modelling a Supplementary Vaccination Program of Rubella Using the 2012⁻2013 Epidemic Data in Japan.
    Kayano T; Lee H; Nishiura H
    Int J Environ Res Public Health; 2019 Apr; 16(8):. PubMed ID: 31027277
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Progress in measles and rubella elimination in Iran.
    Esteghamati A; Gouya MM; Zahraei SM; Dadras MN; Rashidi A; Mahoney F
    Pediatr Infect Dis J; 2007 Dec; 26(12):1137-41. PubMed ID: 18043452
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nationwide rubella epidemic in Japan, 2013.
    Wkly Epidemiol Rec; 2013 Jun; 88(24):251-6. PubMed ID: 23807968
    [No Abstract]   [Full Text] [Related]  

  • 39. Modeling the Transmission of Measles and Rubella to Support Global Management Policy Analyses and Eradication Investment Cases.
    Thompson KM; Badizadegan ND
    Risk Anal; 2017 Jun; 37(6):1109-1131. PubMed ID: 28561947
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modelling the incidence of congenital rubella syndrome in developing countries.
    Cutts FT; Vynnycky E
    Int J Epidemiol; 1999 Dec; 28(6):1176-84. PubMed ID: 10661666
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.